CellCarta Biosciences
0661.567.021 · rovalta.com · 24/09/2026
CellCarta Biosciences
Overview
What does CellCarta Biosciences do?
CellCarta Biosciences is a Public limited company incorporated in 2016. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Charleroi. It employs on average 48,2 ETP workers (FTE).
6041 Charleroi · WallonieSee on map
Joint committees (1)
- 207
Trend over 5 financial years
| 2022 | 2021 | 2020 | 2018 | 2017 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 6 M € | -12.1% | 6,8 M € | +121% | 3,1 M € | +979% | -352,5 k € | +6.3% | -376,1 k € |
| EBITDA | 1,2 M € | -10.5% | 1,4 M € | +104% | 684,7 k € | +143% | -1,6 M € | -52.6% | -1,1 M € |
| Operating result | 880,3 k € | -16.3% | 1,1 M € | +207% | 342 k € | +119% | -1,8 M € | -55.4% | -1,1 M € |
| Net result | 866 k € | -16.3% | 1 M € | +380% | 215,3 k € | +112% | -1,8 M € | -55.3% | -1,1 M € |
| Balance sheet | |||||||||
| Equity | 607,2 k € | +335% | -258,7 k € | +80.0% | -1,3 M € | +54.8% | -2,9 M € | -164% | -1,1 M € |
| Total assets | 27,7 M € | +62.8% | 17 M € | +142% | 7 M € | +211% | 2,3 M € | +371% | 479,5 k € |
| Cash | 353,1 k € | +52.6% | 231,5 k € | -1.6% | 235,2 k € | +22.2% | 192,5 k € | +408% | 37,9 k € |
| Debts | 27,1 M € | +56.9% | 17,3 M € | +107% | 8,3 M € | +62.5% | 5,1 M € | +228% | 1,6 M € |
| Other | |||||||||
| Workforce | 48,2 ETP | +14.2% | 42,2 ETP | +35.7% | 31,1 ETP | +106% | 15,1 ETP | – | |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2022 · 4 active · 13 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
| 0480.172.170 |
Financials
Full financial information
| 2022 | 2021 | 2020 | 2019 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/07/2019 | 01/07/2018 | 01/07/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 30/06/2019 | 30/06/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 6 months | 12 months | 12 months |
| Filing date | 04/02/2025 | 12/09/2024 | 17/01/2023 | 30/10/2020 | 27/02/2020 | 28/02/2019 |
| General meeting | 12/12/2024 | 09/08/2024 | 16/12/2022 | 30/06/2020 | 12/12/2019 | 13/12/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
7 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2022 | 12/12/2024 | 04/02/2025 | French | |
| Abridged model | 31/12/2021 | 09/08/2024 | 12/09/2024 | French | |
| Abridged model | 31/12/2020 | 16/12/2022 | 17/01/2023 | French | |
| Abridged model | 31/12/2019 | 30/06/2020 | 30/10/2020 | French | |
| Abridged model | 30/06/2019 | 12/12/2019 | 27/02/2020 | French | |
| Abridged model | 30/06/2018 | 13/12/2018 | 28/02/2019 | French | |
| Micro model | 30/06/2017 | 02/10/2017 | 31/08/2018 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 5 M€ and 10 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2022 · 4 active · 13 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates05/02/2026DEMISSIONS, NOMINATIONS
- Mandates11/08/2025DEMISSIONS, NOMINATIONS
- Mandates02/06/2025DEMISSIONS, NOMINATIONS
- Mandates06/12/2024DEMISSIONS, NOMINATIONS
- Mandates04/12/2023DEMISSIONS, NOMINATIONS
- Mandates16/12/2021DEMISSIONS, NOMINATIONS
- Mandates03/05/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DENOMINATION
- Mandates05/01/2021DEMISSIONS, NOMINATIONS
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 2022866 k €↓
- 2021Annual accounts 20211 M €↑
- 2020Annual accounts 2020215,3 k €↑
- 2020Name changeCellCarta Biosciences
- 2018Annual accounts 2018-1,8 M €↓
- 2017Annual accounts 2017-1,1 M €
- 2017Name changeCAPRION BIOSCIENCES
- 18/08/2016IncorporationPublic limited company